Strengthened earnings certainty drives valuation recovery

药明康德(603259)
    WuXi AppTec reported a YoY revenue decline of 2.73%, to RMB39.2bn, and a2.5% decrease in adjusted non-IFRS net profit, to RMB10.6bn. However,earnings showed encouraging improvement throughout 2024, resulting in apositive revenue and profit growth in 4Q24. The TIDES business remained theprimary growth engine, with full-year revenue up by 70.1% YoY. The Company'sbacklog as of year-end 2024 expanded significantly, growing 47% YoY toRMB49.3bn. Notably, TIDES backlog experienced a substantial 103.9% YoYincrease in 2024. Fuelled by robust order book, management offered a positiveoutlook for 2025, forecasting 10-15% YoY revenue growth in continuingoperations and further enhancement of the adjusted non-IFRS net profit margin.
    Strong order growth bolsters future revenue visibility. WuXi AppTec'sbacklog at end-2024 grew by a significant 47% YoY, reaching RMB49.3bn.This represents an acceleration from the 35.2% growth seen at the end of3Q24. Positive trends were evident across segments. CDMO businesssecured 25 new Ph3 and commercial projects in 2024 (vs 20 added in 2023).Biology segment returned to positive revenue growth in 4Q24, posting YoYand QoQ increases of 9.3% and 9.2%, respectively, signaling an improvingtrend in early-stage R&D demand. Furthermore, revenue from Top20 globalpharma clients rose by 24.1% YoY (excl. COVID related projects), expeditingfrom the 23.1% growth in 9M24. These metrics underscore the increasingvisibility of the Company's future revenue. Given the positive outlook for futuredemand, the Company plans to boost capex by 75%-100% YoY in 2025 toRMB7-8bn.
    TIDES business sustains strong growth trajectory. TIDES revenue in2024 climbed 70.1% YoY, with backlog expanded by 103.9% YoY. Underlyingdemand for polypeptide manufacturing remains robust in the market. TheCompany's polypeptide capacity reached 41k liters by end-2024, with plansfor a further increase exceeding 100k liters by late 2025, demonstrating WuXiAppTec’s commitment to meeting the growing customer demand. Mgmtanticipates TIDES revenue growth of over 60% YoY in 2025.
    Ongoing commitment to shareholder returns. Amidst macroeconomicuncertainties in 2024, WuXi AppTec strengthened its commitment toshareholder returns. The Company completed RMB4.0bn in sharerepurchases and cancellations in 2024 and maintained a dividend payoutratio of 30% for the year. To further enhance returns, mgmt announced a onetime special dividend of RMB1.0bn, alongside a 2025 interim dividend. Mgmtalso indicated plans to repurchase RMB1.0bn of A-shares in 2025.
    Maintain BUY. We raise our TP from RMB78.51 to RMB94.05 (based on a10-year DCF model with WACC of 9.42% and terminal growth of 2.0%), tofactor in the earnings recovery. We forecast the continuing operation revenueto grow by 14.4%/ 15.2%/ 16.3% YoY and adjusted non-IFRS net income togrow by 11.7%/ 19.0%/ +16.1% YoY in 2025E/ 26E/ 27E, respectively. Our2025E/ 26E/ 27E forecasts of adjusted non-IFRS profit are 6.9%/ 14.9%/19.6% higher than consensus.

24财年业绩稳健，受益于产业链自主可控趋势，上调至“买入”评级

深南电路(002916)
    深南电路发布2024财年业绩。公司收入同比增长32.4%至179亿元人民币，高于我们/彭博一致预期2%/7%。净利润同比增长34.3%至19亿元人民币，符合我们的预测，但低于彭博一致预期2%。期内毛利率提升至24.8%（2023年为23.4%），主要是随着需求恢复而改善；但受到新建工厂产能爬坡的影响，部分抵消。我们将公司2025/26年的收入预测分别上调15%/21%，主要由于1）产能利用率的提升（2025年1季度约为90%），2）国内云厂商资本支出加速，拉动公司数据中心、AI相关收入的增长，3）高端自动驾驶应用的渗透率快于预期，推动汽车PCB收入增长。同时，我们将公司2025/26财年的净利润预测上调12%/16%，其中毛利率略有下降，部分抵消了收入增长的影响（随着广州工厂产能投产，设备、原材料和人力成本将被计入生产成本）。上调至“买入”评级，目标价146.81元人民币（前目标价：115元人民币），对应2024-26财年28.5%的净利润复合年增长率，以及1.1倍PEG。
    PCB业务收入同比增长30%至105亿元人民币，得益于数据中心（占PCB收入的20%）和汽车业务（占约14%）的强劲需求，但电信业务（收入占比<40%）在2024年承压。2024年PCB业务毛利率提升至31.6%（2023年为26.6%），得益于公司产能利用率的提升和产品组合的优化（AI相关产品的占比增加）。PCBA业务同比增长33.2%，公司把握住数据中心、汽车市场的需求，拉动收入增长，同时毛利率维持在14.4%。我们预计，在这两个市场快速增长的推动下（国内AI领域资本支出的大幅增加、自动驾驶方案渗透率的提升），公司2025年PCB业务收入将同比增长25%，毛利率维持在当前的31%水平。
    基板业务收入同比增长37.5%至32亿元人民币。因下游市场补库存的拉动，基板业务的增长主要集中在上半年。该业务毛利率承压（2023/24年为23.9%/18.2%），主要受广州工厂产能爬坡、原材料成本上升（管理层表示金价在下半年增长20%+）、下半年BT基板需求疲软的影响。若剔除广州工厂产能爬坡因素，BT基板在下半年的毛利率较上半年下降约2个百分点（vs.整体部门毛利率下降10多个百分点）。我们预计公司2025年基板业务收入将同比增长18%，主要由存储产品收入快速增长驱动。毛利率仍受到广州工厂持续爬坡带来的影响，预期将温和上升至19.5%。
    上调至“买入”评级，目标价上修至146.81元人民币。新目标价基于31倍5年历史平均远期市盈率。我们注意到深南电路在行业下行周期中的表现优于预期。展望未来，公司凭借在PCB市场的领先地位和FC-BGA基板产线的扩张，有望成为中国半导体产业链自主可控趋势下的受益者。

Solid FY24 results; Upgrade to BUY being key beneficiary in domestic localization

深南电路(002916)
    Shennan released its FY24 results. Revenue went up by 32.4% YoY toRMB17.9bn, 2%/7% above our estimate/BBG consensus. Net profit rose by34.3% YoY to RMB1.9bn, in-line with our estimate but 2% below BBG consensus.During the period, GPM was 24.8% (vs. 23.4% in FY23), showing gradualimprovement as demand recovered but offset by new factory ramp-up. We reviseup our revenue forecasts by 15%/21% for FY25/26E, reflecting 1) higherutilization (~90% for 1Q), 2) higher-than-expected DC/AI-related revenue asdomestic Cloud companies increase capex budget and 3) better auto PCBrevenue growth as high-end autonomous driving systems may have faster-thananticipated penetration. Meanwhile, we revise up our NP estimates by 12%/16%in FY25-26E, partially offset by lower GPM estimates considering the continuouscapacity ramp-up of Guangzhou factory with costs from equipment, labor and rawmaterials now recognized in COGS as production ramps up. Upgrade to BUY,with new TP of RMB146.81 (previous: RMB115), implying a NP CAGR of 28.5%and PEG of 1.1x during 2024-26E.
    PCB sales grew by 30% YoY to RMB10.5bn, driven by robust demand indata centers (20% YoY) and auto (~14% of total sales), despite a telecomdecline (contributing to less than 40% of total PCB sales in FY24). PCB GPMimproved to 31.6% in FY24, compared to 26.6% in FY23, reflecting highercapacity utilization and an enhanced product mix consisting of more AIrelated products. PCBA segment increased by 33.2% YoY, also driven byrobust data center and auto sales, with a stable GPM of 14.4%. We expectthe segment revenue to grow 25% YoY in 2025, driven by strong growth inDC/auto markets (domestic AI capex and higher penetration of autonomousdriving vehicles). We project GPM will be stable at current ~31% level.
    Substrate sales grew by 37.5% YoY to RMB3.2bn. The growth weightedmore towards 1H24 as demand was strong due to inventory restockingbehaviors. The segment experienced margin pressure (18.2% in FY24 vs.23.9% in FY23) due to capacity ramp-up, rising material costs (specificallygold price, which surged by more than 20% in 2H24, per mgmt.), and weakerBT substrate demand in 2H24. Excluding the impact of the initial capacityramp-up of Guangzhou factory, BT substrate’s GPM in 2H would have been2ppts lower compared to 1H (instead of 10ppts drop). We expect substraterevenue to grow by 18% YoY in 2025E, led by higher growth in memoryproducts as demand recovers. GPM may rise modestly to 19.5%, consideringthe ongoing ramp-up dilution, in our view.
    Upgrade to BUY, with new TP of RMB146.81. The new TP is based on 5-year avg. historical forward PE of 31.0x. We believe SCC performed betterthan expected during the sectoral downcycle. Looking forward, the companyis set to ride the tailwind of domestic localization with its leading position inPCB market and capacity addition from its FC-BGA substrate line.

拥抱AI，与联影智能深入协同

联影医疗(688271)
    联影智能是联影医疗控股股东联影集团旗下的AI医疗公司，联影集团持股24.1%。联影智能以全栈全谱的医学影像AI赋能临床、科研及影像设备。联影医疗与联影智能深入协同合作，已在全线设备产品中融入AI应用，通过高效的诊断辅助和数据处理能力，优化医疗设备的使用体验，并提升影像和放疗设备性能及成像质量。我们认为，依托与联影智能的业务协同，联影医疗正从传统设备制造商转型为智慧影像解决方案提供商。联影医疗将凭借“设备+AI”的领先优势进一步巩固行业龙头地位，构建更强的竞争壁垒。
    全栈全谱AI布局，多维度赋能医疗场景。联影智能的全栈全谱医学影像AI能力贯穿成像、筛查、随访、诊断、治疗的完整工作流，覆盖XR、CT、MR、MI等多模态场景。联影智能的业务分为三个方向：1）赋能临床：业务占比约60-70%，利用AI帮助医生进行临床任务和决策，目前主要在影像科落地。截至2024年底，联影智能已推出超100款医疗AI产品，共获得12张NMPA三类证，21张NMPA二类证，13款应用获CE认证，15款应用获FDA认证。2）赋能科研：业务占比约20%，即协助医生进行科研工作。3）赋能设备：业务占比约10%，即与联影医疗合作，助力影像设备的智能化升级与性能提升。目前，在国内影像AI的应用方面，联影智能具备较强的先发优势，其获证数量远超GPS等国际同行。
    软硬件协同创新，共建“设备+AI”一体化竞争力。联影医疗和联影智能形成了软硬件协同创新优势，引领全球“医疗设备+AI”的技术创新。例如，联影智能将AI算法直接嵌入联影医疗的影像设备，实现患者智能摆位、扫描参数智能优化、图像重建加速等功能，提升成像效率和质量。我们认为，AI可加强影像设备竞争力与议价能力，“影像诊疗+AI”带来的市场增量将一部分体现在联影医疗的设备收入中。目前，AI及智能化应用已覆盖联影医疗的全产品线。凭借与联影智能的协同合作，联影医疗已形成“设备+AI”一体化竞争力。在政策驱动设备更新与AI应用渗透率提升的背景下，联影医疗的收入有望持续快速增长。

Solid results despite supply chain constraints; expect for another strong year in 2025

中际旭创(300308)
    Innolight released its FY24 prelim. results. The company expects NP to go upby 111.6%-166.9% to RMB4.6bn-5.8bn. Mid-point value of RMB5.2bn implies139.2% YoY growth and is largely in-line with consensus and our estimate(3.2%/1.4% below, respectively). We continue to view Innolight as a keydomestic beneficiary amid the ongoing AI infra. investment cycle driven byresilient demand for more computing power globally. Recent additional AIspending developments (i.e., $60-65bn from Meta, $12bn from ByteDance, andup to $500bn Stargate project) show intensifying capex in AI. We also believethe recent fear of CPO solution becoming mainstream is overly concerned.Recent share price pullbacks provide excellent buying opportunities. MaintainBUY on Innolight with TP unchanged at RMB186.0.
    4Q24 NP is expected to improve sequentially on margin expansionwith favourable product mix, which is partially offset by the impactfrom supply chain bottleneck. The company’s mid-point NP grew by64.9% YoY/3.8% QoQ in 4Q24, compared to 33.7%/3.3% QoQ in 2Q/3Q24.We think the sequential slowdown in growth in 2H24 was mainly due to EMLshortage that caused a delay to shipments, while the demand for 400/800Goptical transceivers remained strong. The impact of component shortage on2H24 earnings was offset by margin upside (favourable product mix plushigher yield). Mgmt. expects this issue will be largely alleviated in 2H25.
    800G to be the main growth driver in 2025, while 1.6T to ramp upsequentially. In FY24, Innolight saw strong demand for its 400/800Gproducts with product mix leaning heavier towards 400G. We anticipate amore favourable product mix with a higher portion of 800G sales in 2025,with additional contribution from 1.6T products. Mgmt. expects highervolume to come in 2026 as more cloud companies deploy 1.6T products.The company has also ramped up its 400G SiPh products throughout FY24,with 800G SiPh products expected to begin volume shipments in 1Q25.
    Multiple major AI spending developments fuel AI infra. buildoutmomentum： 1） $500bn AI initiative Stargate Project in the next fouryears, 2) $60-65bn capex planned by Meta for 2025E, up as much as 70%YoY compared to 2024 (Bloomberg), largely driven by AI spending increaseand deployment of a new datacenter. ByteDance also considered US$12bnin AI capex for 2025. Reliance is reported to build the world’s largestdatacenter. These spending sprees indicate that demand for AI computepower is still in full swing with robust outlook. AI networking products,such as optical transceivers, should continue to enjoy the AI tailwind.
    Imminent ramp-up + adoption of CPO solution seem to be overlyconcerned. Admittedly, CPO normally reduces power consumption by over30%, there are still several technical hurdles to overcome to make itmainstream (i.e., low yield, high repair cost). From our communication withindustry experts, we believe networking players are exploring LRO/LPO toachieve some power savings as at least one DSP is typically removed inthese technical approaches. Maintain BUY, with TP unchanged atRMB186, corresponding to ~27x FY25E P/E. The stock is currentlytrading at 18.5x FY25E P/E, which we believe underestimates thecompany’s future growth potential. Potential risks include: 1) China-UStrade tensions, 2) rising raw material costs, and 3) slower-than-expectedramp-up speed.

Embracing AI and moving on to a new growth trajectory

生益科技(600183)
    Shengyi Tech released its preliminary FY24 earnings. The company expects itsNP to rise by 46.0-54.6% YoY to RMB1.7bn-1.8bn. Mid-point NP of RMB1.75bn(+50.3% YoY) is lower than Bloomberg consensus/our estimate by 6.1%/3.3%.Our forecast of RMB1.8bn is at the high-end of the range. We are optimistic aboutShengyi Tech, as the company benefits from growing AI-related demand,particularly through its ultra-low-loss CCL products used in AI supply chain.Maintain BUY with TP adjusted to RMB34.5, corresponding to 30.6x 2025EP/E (prev. TP: RMB28.75) as we think the sector is 1) embarking upon anupcycle, and 2) the company’s CCL products are expected to be used inNvidia’s upcoming AI accelerators in 2025. .
    Shengyi Tech has climbed out of the trough with revenue improvement(from both CCL and PCB, with higher growth from PCB) and net marginexpansion (up +1.8ppts) in 2024. By segment, in the preliminary results, 1)CCL/Pregreg’s NP is estimated to be RMB1,421mn, up 19.5% YoY, drivenby higher production and sales volume, favourable product mix, as well asbetter GPM. 2) PCB’s (~20% rev. contribution) NP is estimated to beRMB329mn (mid-point of Shengyi Electronics’ revenue estimate), vs. net lossof RMB25mn in 2023. The turnaround in bottom-line is driven by increasingdemand for multilayer PCB.
    Despite sequential net profit decline in 4Q24, we think Shengyi Tech iswell-positioned to enjoy the significant upside as dollar value of PCBused in upgraded datacenter (new GPUs, cooling tech, high-densityinterconnect, etc) has increased substantially. Mid-point 4Q24 NP isestimated to be RMB378mn, up 43% YoY and down 14% QoQ. NPM isestimated to be ~7.4% vs. 8.6%/6.3% in 3Q24/4Q23. By segment, 1)CCL/Pregreg’s NP is estimated to be ~RMB235mn, down 14% YoY and down33% QoQ. We believe it is likely due to weaker-than-expected demand innon-AI market (e.g., consumer electronics), which has suppressed ASPrecovery. Meanwhile, copper price remained at its highs (avg. price in 3Q24:~US$9.9k/t). 2) PCB’s NP is estimated to be RMB142mn, up 57% QoQ (vs.4Q23 was net loss of RMB7mn). We think it is a continuation of 9M24 growthmomentum driven by rising contribution (20.9% YoY in 9M24) from serverrevenue (42.5% of PCB sales). (report)
    Maintain BUY. We like Shengyi Tech given 1) products adopted in AImarket (Ultra Low-loss and Extreme Low-loss CCL products), 2) leadingmarket position (No.2 with 12% market share of the global CCL market in2023 per Prismark). We maintain our NP growth forecast for 2025 at 51%YoY. We believe the sector is on the way of an upcycle plus AI theme. NewTP is RMB34.5, based on 1SD above 5-year hist. avg, corresponding to30.6x 2025E P/E. Potential risks include US-China tariff escalation, rising USinterest rates, exchange rates fluctuation, etc.

Expect sequential improvement ahead

韦尔股份(603501)
    Willsemi released FY24 prelim results. Rev. is expected to grow by 20.9% to22.8% YoY to the range of RMB25.4bn to RMB25.8bn, driven by a higherpenetration rate of CIS products in high-end smartphone market (smartphoneCIS: 52% of CIS revenue in 1H24) and autonomous driving (AD) tech (auto CIS:31%). Mid-point rev. was slightly below BBG consensus/our estimate by3.2%/2.6%. Net profit is expected to be between RMB3.2bn and RMB3.4bn, up468% to 504% YoY, which mgmt. attributed to market share expansion (11% ofglobal CIS market in 2023 per Yole) and improved GPM (9M24/FY23:29.6%/21.8%). Looking forward, we expect Willsemi to be a key beneficiary of 1)domestic consumer subsidy plan and 2) rapid expansion of several key markets,such as EVs (AD), edge AI (e.g. AI glasses, XR headsets), robotics (e.g. humanoid& industrial robots), etc. Maintain BUY, with TP unchanged at RMB130.
    Sustained sequential growth drives strong 2024 performance. 4Q24 midpoint revenue is expected to be RMB6.7bn, up 12.8% YoY but down 1.7%QoQ, after a record-high quarterly revenue at RMB6.8bn in 3Q24. Revenuegrew sequentially in 2Q/3Q24 by 14.2%/5.7% on the company’s 1) continuedmarket share expansion in flagship smartphone models with premiumproducts such as OV50H/OV50K40, 2) robust camera shipments as smartdriving solutions (e.g., OX08D10) expanded from premium models to massmarket vehicles, and 3) increased integration of AI-driven tech.
    CIS revenue estimated to grow 26% in 2025, driven by higher number ofcameras used in EVs/robotaxis and benefiting from China digitalproduct subsidy plan. Auto/smartphone CIS sales accounted for 24%/40%of the company’s total revenue in 1H24. We think these two segments willcontinue to be the key growth drivers, with 35%/23% revenue growth projectedfor 2025E. We see the number of sensors adopted in vehicles growingsignificantly for safety concerns. It is common to see 10+ cameras on vehicles(Alphabet-owned self-driving car company Waymo has the most with 29cameras). As for smartphone CIS, we think Willsemi will be a key beneficiaryof China’s new consumer subsidy plan, which offers 15% subsidies onsmartphones, tablets and smart wearables priced below RMB6k (~US$830)for up to RMB500. We expect the plan to stimulate demand.
    Continued growth driven by market share expansion and rising demandacross key segments. We believe the company is set for further growthdriven by market share gains and rising demand across several markets.Meanwhile, given the intensified competition, local OEMs are also looking fordomestic components/solutions, benefitting Willsemi and other Chinesenames. The stock is currently trading at RMB108.3, est. 38x 2024 P/E or 26x2025E P/E. We forecast 2025 EPS growth to exceed 40%. Maintain BUY,with TP at RMB130, corresponding to 31.7x 2025E P/E.

Entering 2025 with a clean slate,with the worst left behind

闻泰科技(600745)
    Wingtech announced its preliminary FY24 results. The company expects a netloss to be around RMB3.5-4.55bn (vs. RMB1.1bn NP in FY23). Mgmt. attributedthe NL primarily to 1) impairment related to the sale of ODM business announcedin Dec (link), 2) a write-down on deferred tax assets, and 3) further goodwillimpairments (RMB600mn/RMB500mn in 2022/23, with RMB200mn to be fullyimpaired in 2024). Despite short-term financial setbacks, we believe Wingtech isbetter-positioned for LT value creation as it moves forward with a lighter load asit transforms itself to a predominately semiconductor-focused company. MaintainBUY with TP unchanged at RMB52.
    Net loss in FY24 due to one-off impairments from ODM spin-off. PerCounterpoint, the top three ODM players (Longcheer, Huaqin, Wingtech)accounted for 75% of total market in 1H24 in China. Wingtech ranked thirdwith 17% share, down 3ppts vs. 1H23. Despite a challenging 1H24, its ODMbusiness continued to improve in 4Q (after +46%/15% YoY/QoQ in 3Q), witha record revenue (est. double-digit YoY and single-digit QoQ). Excluding theimpairments (ODM business spin-off, write-down on DTA, and goodwill), thesegment turned profitable in 4Q as mgmt. expected. However, ODM is a lowmargin business, with the top three ODM players in China seeing <3% NPMon average in 9M24. We see No.2 player Huaqin (603296 CH, NR) is activelydiversifying its business portfolio towards higher-margin opportunities(recently acquired 75% of HCTRobot). We believe Wingtech is betterpositioned now as it moves forward with a lighter load.
    Semi business continued to show resilience amid seasonal slowdown.Semi business revenue grew sequentially in FY24 (2Q/3Q: 10/15% QoQ).While 4Q24 sales faced seasonal softness, the business still recorded singledigit YoY (~7%) and flattish QoQ growth, driven by strong demand inconsumer, data center, and auto sectors. Notably, China contributed ~40%of total semi revenue, offsetting weakness overseas resulting from continuedinventory correction. 4Q GPM was near 2Q level (1Q/2Q/3Q: 31.0%/38.7%/40.5%). Mgmt. expects overseas auto OEMs to resume restocking in2025, with auto revenue currently accounting for 60% of total semi revenue.
    Looking forward, we expect to see more upside in Wingtech’s valuation,lifted by 1) increasing semiconductor revenue share, 2) robust domestic autodemand with gradual recovery overseas, and 3) a re-rating opportunity givenits business transformation to being a semi-centric company. Maintain BUY,with TP unchanged at RMB52, corresponding to 24.8x FY25E P/E, basedon unchanged financial forecasts. Potential risks include heightened USChina trade relations, unfavourable exchange rates, and weaker-thanexpected overseas auto inventory correction.

Valuation to improve on ODM business spin-off

闻泰科技(600745)
    On December 31, 2024, Wingtech signed a “Letter of Intent for Sale” for ninewholly-owned ODM subsidiaries with Luxshare Limited in an all-cash deal. Thismove follows its recent addition to the US trade blacklist (news). According tomgmt., this transaction serves two primary purposes: (1) to align with the riskpreferences of certain ODM clients, and (2) to mitigate potential risks to itssemiconductor leg. The deal reflects a broader 2025 trend of event-driven M&Aopportunities in China's semiconductor sector amid strategic geopolitical shiftsand favourable policies, as indicated in our 2025 outlook report as a newinvestment theme (link). Maintain BUY on Wingtech, with TP unchanged atRMB52.
    The sale exclusively involves its Android-focused ODM business, aburden on the company’s financial performance and valuation.Together, these subsidiaries held a total asset value of RMB28.2bn as of9M24, representing 36.1% of the company’s total assets and over 50% oftotal revenue (triggering one of CSRC’s asset restructuring regulations) in3Q24. In 9M24, the ODM segment contributed ~79% of total revenue butrecorded a substantial net loss of RMB1.2bn.
    Wingtech will focus on its high-margin semiconductor business,Nexperia. In 9M24, semi segment generated RMB10.9bn in sales (~20%of total revenue), with GPM at 37% (RMB4bn) and NPM at 16%(RMB1.7bn), outperforming the company’s overall 9% GPM and 1% NPMduring the same period. In 2Q/3Q24, semi segment saw sequential growthof 6%/6%, driven by 1) strong domestic auto sales, recovering consumerelectronics and robust computing demand. We expect the company’s semisegment sales to grow by 11.8%/12.9% in FY25/26E, compared toBloomberg consensus of 9%/9%.
    Maintain BUY, with TP unchanged at RMB52, corresponding to 24.8xFY25E P/E. We expect this business transformation will lead to a highervaluation for Wingtech, as it has almost transformed into a predominatelysemi-focused company. The company currently trades at 17.7x/12.2xFY25/26E P/E, which is appealing comparing to its domestic peers thattrade at an average 25/26E P/E of 30.3x/23.8x. Potential risks include:heightened China-US trade relations, and unfavourable exchange rates.